ghk cu use GHK-Cu GHK-Cu - 200MG (Topical) -

Generally well-tolerated in research settings Mild nausea with higher doses Injection site redness or discomfort Rare: Dizziness or lightheadedness Potential effect on blood pressure (monitor if hypertensive) BPC-157 (Oral) is banned from 503A compounding pharmacies

However, as with any performance-enhancing compound, especially one that isnt FDA-approved, there are still important safety considerations to keep in mind

Jung YS, Lee JH, Bae JM, Lee DW, Kim GM

The administration of a synthetic peptide (FOXO4-DRI = FOXO4-D-Retro-Inverso) to avoid the interaction between FOXO4 and p53 leads to a decrease of irradiated-induced senescent fibroblasts viability